Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...
University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...
The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...
Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...
The field of cancer treatment is witnessing rapid advancements due to progress in proteomics, genomics, and drug discovery. These technologies have ...
Asymptomatic brain metastasis in stage 4 breast cancer requires reevaluation of screening guidelines
A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback